Aurinia Pharmaceuticals Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Robertson Stephen P. | EVP, General Counsel | Sale | 19,402 | $8.94 | $173,454 | 303,364 | Mar 2, 2023 |
| Martin Michael Robert | Chief Business Officer | Award / Grant | 107,202 | — | — | 259,162 | Mar 2, 2023 |
| Habig Scott Michael | Chief Commercial Officer | Award / Grant | 170,188 | — | — | 312,719 | Mar 2, 2023 |
| Knappertz Volker | EVP, Research and Development | Award / Grant | 191,462 | — | — | 344,274 | Mar 2, 2023 |
| Greenleaf Peter | Chief Executive Officer | Award / Grant | 667,407 | — | — | 1,015,718 | Mar 2, 2023 |
| Donley Matthew Maxwell | Ex VP, Internal Operations | Purchase | 10,000 | $4.66 | $46,600 | 27,927 | Nov 21, 2022 |
| Habig Scott Michael | Chief Commercial Officer | Purchase | 5,000 | $5.02 | $25,100 | 5,000 | Nov 9, 2022 |
| Martin Michael Robert | Chief Business Officer | Purchase | 30,000 | $5.16 | $154,800 | 89,512 | Nov 7, 2022 |
| Jayne David R.W. | — | Option Exercise | 10,000 | $3.62 | $36,200 | 40,000 | May 18, 2022 |
| MacKay-Dunn R. Hector | — | Purchase | 5,000 | $11.00 | $55,000 | 11,000 | Mar 9, 2022 |
| MILNE GEORGE M JR | — | Purchase | 5,000 | $10.82 | $54,100 | 50,000 | Mar 4, 2022 |
| Martin Michael Robert | Chief Business Officer | Sale | 4,849 | $12.01 | $58,236 | 59,512 | Mar 2, 2022 |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | Sale | 3,052 | $12.01 | $36,655 | 16,224 | Mar 2, 2022 |
| Miller Joseph M | Chief Financial Officer | Award / Grant | 8,500 | — | — | 9,670 | Mar 2, 2022 |
| Colao Massimilano | Chief Commercial Officer | Sale | 3,205 | $12.01 | $38,492 | 13,495 | Mar 2, 2022 |
| Greenleaf Peter | Chief Executive Officer | Sale | 9,068 | $12.01 | $108,907 | 32,967 | Mar 2, 2022 |
| Robertson Stephen P. | EVP, General Counsel | Award / Grant | 8,500 | — | — | 11,682 | Mar 2, 2022 |
| Solomons Neil | Chief Medical Officer | Award / Grant | 8,500 | — | — | 95,799 | Mar 2, 2022 |
| Huizinga Robert Bindert | EVP of Research | Award / Grant | 8,500 | — | — | 74,228 | Mar 2, 2022 |
| Hagan Joseph P | — | Sale | 634 | $23.29 | $14,766 | 3,500 | Jan 3, 2022 |
| Leversage Jill | — | Purchase | 1,600 | $20.04 | $32,064 | 5,300 | Dec 13, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 29,000 | $28.82 | $835,780 | 66,861 | Nov 11, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 90,000 | $31.17 | $2,805,300 | 97,299 | Nov 11, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 45,000 | $31.64 | $1,423,800 | 137,299 | Nov 1, 2021 |
| Martin Michael Robert | Chief Business Officer | Option Exercise | 45,000 | $3.20 | $144,000 | 221,861 | Nov 1, 2021 |
| Huizinga Robert Bindert | EVP of Research | Sale | 130,000 | $29.75 | $3,867,500 | 65,728 | Oct 25, 2021 |
| Huizinga Robert Bindert | EVP of Research | Option Exercise | 16,000 | $2.63 | $42,080 | 122,092 | Sep 21, 2021 |
| Martin Michael Robert | Chief Business Officer | Option Exercise | 10,000 | $18.38 | $183,800 | 264,361 | Sep 21, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 14,000 | $21.73 | $304,220 | 206,861 | Sep 14, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 25,000 | $19.80 | $495,000 | 176,861 | Sep 14, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 150,000 | $19.84 | $2,976,000 | 137,299 | Sep 13, 2021 |
| Huizinga Robert Bindert | EVP of Research | Sale | 22,500 | $21.75 | $489,375 | 106,092 | Sep 10, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 7,500 | $18.10 | $135,750 | 176,861 | Sep 7, 2021 |
| Huizinga Robert Bindert | EVP of Research | Sale | 5,000 | $18.30 | $91,500 | 138,592 | Sep 7, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 22,500 | $17.81 | $400,725 | 184,361 | Aug 26, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 5,000 | $15.85 | $79,250 | 137,299 | Aug 25, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 45,000 | $16.03 | $721,350 | 142,299 | Aug 9, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 5,000 | $16.01 | $80,050 | 206,861 | Aug 9, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 5,000 | $13.86 | $69,300 | 211,861 | Jul 28, 2021 |
| Martin Michael Robert | Chief Business Officer | Sale | 5,000 | $13.76 | $68,800 | 216,861 | Jun 22, 2021 |
| MacKay-Dunn R. Hector | — | Purchase | 1,000 | $11.14 | $11,140 | 3,000 | May 11, 2021 |
| Donley Matthew Maxwell | Ex VP, Intern'l Operations | Purchase | 9,900 | $10.07 | $99,693 | 9,900 | May 11, 2021 |
| Greenleaf Peter | Chief Executive Officer | Purchase | 2,992 | $11.11 | $33,241 | 13,453 | May 11, 2021 |
| Martin Michael Robert | Chief Business Officer | Option Exercise | 20,000 | $3.02 | $60,400 | 221,861 | May 11, 2021 |
| Leversage Jill | — | Purchase | 2,500 | $10.96 | $27,400 | 3,700 | May 11, 2021 |
| Huizinga Robert Bindert | Ex Vice President of Research | Option Exercise | 40,000 | $3.02 | $120,800 | 143,592 | May 11, 2021 |
| Miller Joseph M | Chief Financial Officer | Purchase | 1,000 | $9.74 | $9,740 | 1,000 | May 11, 2021 |
| Solomons Neil | Chief Medical Officer | Sale | 40,000 | $13.49 | $539,600 | 187,299 | Mar 12, 2021 |
| MILNE GEORGE M JR | — | Purchase | 5,000 | $13.00 | $65,000 | 45,000 | Mar 5, 2021 |
| Leversage Jill | — | Purchase | 1,200 | $16.03 | $19,236 | 1,200 | Jan 29, 2021 |